Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination

Published byKathryn Brooks Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination"— Presentation transcript:

1 Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination
Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination. (A) Experimental plan to evaluate FtLVS-GFP-Lux imaging system. (B) Time-lapse imaging of splenocytes from non-vaccinated mouse and LPS vaccinated mouse. (C) Flow cytometry analysis of cells from organs of non-vaccinated mouse and LPS vaccinated mouse. (D) Bacterial burden on target organ after FtLVS-GFP-Lux challenge by LPS amount of vaccination. (E) Ex-vivo bioluminescence imaging of FtLVS-GFP-Lux infected mouse by LPS amount of vaccination. (F) Whole body bioluminescence imaging of FtLVS-GFP-Lux infected mouse with or without LPS vaccination. (G) Survival rate of infected mice with or without LPS vaccination. FtLVS, Francisella tularensis LVS; LPS, lipopolysaccharide; FACS, fluorescence-activated cell sorting; PBS, phosphate buffered saline; CFU, colony forming unit. Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination. (A) Experimental plan to evaluate FtLVS-GFP-Lux imaging system. (B) Time-lapse imaging of splenocytes from non-vaccinated mouse and LPS vaccinated mouse. (C) Flow cytometry analysis of cells from organs of non-vaccinated mouse… Clin Exp Vaccine Res Jul;7(2):

Download ppt "Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination"

Similar presentations

Preclinical evaluation of safety, efficacy, immunogenicity of a recombinant rBCG Pasteur B vaccine Group B4 March 16, 2011 Adane Miheret, Tewodros Tariku.

Preclinical evaluation of safety, efficacy, immunogenicity of a recombinant rBCG Pasteur B vaccine Group B4 March 16, 2011 Adane Miheret, Tewodros Tariku.
1 University of Texas San Antonio Update on F. tularensis attenuated vaccine strain construction and evaluation TVD Team 2/19/08 tech call.

1 University of Texas San Antonio Update on F. tularensis attenuated vaccine strain construction and evaluation TVD Team 2/19/08 tech call.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Genetic Background on the Response to Bacterial.

Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Genetic Background on the Response to Bacterial.
Targeting Improves MSC Treatment of Inflammatory Bowel Disease

Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system  Zhiping Li, Huizhi Lin, Shiqi Yang, Anna.

Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system  Zhiping Li, Huizhi Lin, Shiqi Yang, Anna.
S2 Fig. Phenotype of donor cells in the spleen and bone marrow of male mice. Splenocytes and bone marrow were isolated from male donor mice and stained.

S2 Fig. Phenotype of donor cells in the spleen and bone marrow of male mice. Splenocytes and bone marrow were isolated from male donor mice and stained.
Respiration 2012;83:74–80 - DOI: /

Respiration 2012;83:74–80 - DOI: /
E-LIFE JOURNAL IF=8.5.

E-LIFE JOURNAL IF=8.5.
Fig. 1. Immune response anti-tetanus toxoid by enzyme-linked immunosorbent assay. Groups were immunized with two doses (3 weeks apart) and 2 weeks after.

Fig. 1. Immune response anti-tetanus toxoid by enzyme-linked immunosorbent assay. Groups were immunized with two doses (3 weeks apart) and 2 weeks after.
Core Facility Operator

Core Facility Operator
Fig. 2. Infection by lentivirus

Fig. 2. Infection by lentivirus
Figure 1 Protective effects of acellular pertussis vaccines (A–F) in the respiratory infection model. Mice were challenged by exposure to an aerosol of.

Figure 1 Protective effects of acellular pertussis vaccines (A–F) in the respiratory infection model. Mice were challenged by exposure to an aerosol of.
Volume 17, Issue 9, Pages (September 2009)

Volume 17, Issue 9, Pages (September 2009)
Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.

Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.
Volume 43, Issue 5, Pages (November 2015)

Volume 43, Issue 5, Pages (November 2015)
Volume 22, Issue 1, Pages (January 2014)

Volume 22, Issue 1, Pages (January 2014)
Targeting Improves MSC Treatment of Inflammatory Bowel Disease

Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 15, Issue 2, Pages (February 2014)

Volume 15, Issue 2, Pages (February 2014)
Volume 22, Issue 1, Pages e4 (July 2017)

Volume 22, Issue 1, Pages e4 (July 2017)
Volume 15, Issue 5, Pages (May 2007)

Volume 15, Issue 5, Pages (May 2007)

Similar presentations

Ads by Google